tiprankstipranks
Trending News
More News >

Amphastar downgraded to Neutral from Overweight at JPMorgan

JPMorgan downgraded Amphastar (AMPH) to Neutral from Overweight with a price target of $30, down from $45. The company has seen continued setbacks on the pipeline front, the analyst tells investors in a research note. The firm says that while Amphastar’s generic business remains better positioned than some peers, both glucagon and epinephrine are eroding faster than the Street was expecting. As such, it sees better opportunities elsewhere in the space.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue